Business
60 Degrees Pharmaceuticals and NDT Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
ORLANDO, FLORIDA / ACCESS Newswire / October 31, 2025 / RedChip Companies will air interviews with 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) and NDT Pharmaceuticals Inc. (OTC:NDTP) on the RedChip Small Stocks, Big Money™show, a sponsored program ...
About this update from Ndt Pharmaceuticals Inc.
[{"type":"text","content":"ORLANDO, FLORIDA / ACCESS Newswire / October 31, 2025 / RedChip Companies will air interviews with 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) and NDT Pharmaceuticals Inc. (OTC:NDTP) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV this Saturday, November 1, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.","length":398,"tagName":"p"},{"type":"text","content":"Access the interviews in their entirety at:","length":43,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"SXTP: https://www.redchip.com/assets/access/sxtp_access","length":55,"tagName":"p"}]},{"val":[{"type":"text","content":"NDTP: https://www.redchip.com/assets/access/ndtp_access","length":55,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":110,"olType":false},{"type":"text","content":"Geoffrey Dow, PhD, CEO of 60 Degrees Pharmaceuticals, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to discuss the Company's mission to combat infectious diseases with innovative, small-molecule therapeutics. Dr. Dow will highlight the potential of ARAKODA® (tafenoquine), an FDA-approved antimalarial developed with the U.S. Army, and its expanding commercial footprint in the U.S. He will also outline the company's plan to expand FDA approval for tafenoquine to babesiosis-a growing tick-borne illness, incidence of which management believes is vastly underrepresented by CDC estimates and for which there is no FDA-approved therapy. 60 Degrees Pharmaceuticals has two clinical trials (hospitalized babesiosis patients and relapsing patients) underway, and initiation of a third planned near-term. 60 Degrees Pharmaceuticals has Orphan Drug status for tafenoquine for babesiosis and patent exclusivity for the malaria indication through 2035.","length":975,"tagName":"p"},{"type":"text","content":"Zach O'Shea, President and CEO of NDT Pharmaceuticals, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to discuss the company's mission to redefine biosafety and wellness through its wholly owned subsidiary, Good Salt Life. Headquartered in Athens, Georgia, Good Salt Life is a vertically integrated innovator in infection control, combining cutting-edge chemical-delivery technology, EPA-approved antimicrobial solutions, and pro...